Sara Sawyer
Concepts (608)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Primates | 19 | 2024 | 133 | 3.710 |
Why?
| | Evolution, Molecular | 17 | 2021 | 502 | 3.680 |
Why?
| | Dengue Virus | 4 | 2026 | 62 | 2.990 |
Why?
| | HIV-1 | 13 | 2026 | 913 | 2.890 |
Why?
| | CD4 Antigens | 7 | 2026 | 136 | 2.790 |
Why?
| | Virus Replication | 16 | 2026 | 526 | 2.760 |
Why?
| | Selection, Genetic | 18 | 2021 | 269 | 2.490 |
Why?
| | Viruses | 6 | 2023 | 165 | 2.330 |
Why?
| | Saliva | 4 | 2026 | 256 | 2.240 |
Why?
| | Exome | 13 | 2025 | 233 | 2.120 |
Why?
| | Genetic Testing | 15 | 2026 | 492 | 1.980 |
Why?
| | Dengue | 4 | 2026 | 92 | 1.940 |
Why?
| | Simian Acquired Immunodeficiency Syndrome | 3 | 2025 | 93 | 1.890 |
Why?
| | Pan troglodytes | 5 | 2025 | 62 | 1.820 |
Why?
| | Mutation | 27 | 2023 | 4093 | 1.700 |
Why?
| | Aotidae | 4 | 2026 | 11 | 1.570 |
Why?
| | Simian Immunodeficiency Virus | 3 | 2025 | 94 | 1.530 |
Why?
| | Host-Pathogen Interactions | 9 | 2021 | 366 | 1.490 |
Why?
| | Rare Diseases | 8 | 2025 | 117 | 1.470 |
Why?
| | RNA, Viral | 6 | 2026 | 693 | 1.370 |
Why?
| | Carrier Proteins | 11 | 2017 | 728 | 1.360 |
Why?
| | Ubiquitin-Protein Ligases | 10 | 2019 | 198 | 1.350 |
Why?
| | Nuclear Proteins | 10 | 2020 | 740 | 1.340 |
Why?
| | Sequence Analysis, DNA | 12 | 2025 | 771 | 1.300 |
Why?
| | Carrier State | 2 | 2021 | 80 | 1.270 |
Why?
| | Viral Proteins | 7 | 2021 | 351 | 1.250 |
Why?
| | Intellectual Disability | 10 | 2025 | 183 | 1.230 |
Why?
| | Host Specificity | 5 | 2018 | 33 | 1.220 |
Why?
| | Receptors, Virus | 6 | 2019 | 91 | 1.220 |
Why?
| | Zoonoses | 3 | 2019 | 39 | 1.180 |
Why?
| | Animals | 59 | 2026 | 38107 | 1.140 |
Why?
| | HIV Infections | 10 | 2026 | 3215 | 1.070 |
Why?
| | Nuclear Pore Complex Proteins | 2 | 2018 | 40 | 1.060 |
Why?
| | Genes, BRCA1 | 5 | 2015 | 45 | 1.060 |
Why?
| | Genomics | 9 | 2026 | 853 | 1.040 |
Why?
| | Saccharomyces cerevisiae | 6 | 2018 | 584 | 1.010 |
Why?
| | Virology | 2 | 2024 | 37 | 0.990 |
Why?
| | Tripartite Motif Proteins | 7 | 2019 | 39 | 0.970 |
Why?
| | Genome | 3 | 2024 | 307 | 0.950 |
Why?
| | Receptors, Transferrin | 3 | 2015 | 28 | 0.930 |
Why?
| | Receptors, CXCR4 | 2 | 2026 | 91 | 0.930 |
Why?
| | Chiroptera | 3 | 2019 | 59 | 0.910 |
Why?
| | Reverse Genetics | 1 | 2025 | 7 | 0.900 |
Why?
| | Gorilla gorilla | 1 | 2025 | 17 | 0.890 |
Why?
| | Flaviviridae | 1 | 2025 | 10 | 0.880 |
Why?
| | Influenza A Virus, H3N2 Subtype | 2 | 2023 | 50 | 0.880 |
Why?
| | Virus Internalization | 5 | 2022 | 65 | 0.870 |
Why?
| | Biological Evolution | 7 | 2024 | 471 | 0.860 |
Why?
| | Humans | 114 | 2026 | 146342 | 0.850 |
Why?
| | Amino Acid Sequence | 20 | 2019 | 2092 | 0.850 |
Why?
| | Viral Tropism | 3 | 2026 | 38 | 0.820 |
Why?
| | High-Throughput Nucleotide Sequencing | 9 | 2025 | 539 | 0.810 |
Why?
| | Saccharomyces cerevisiae Proteins | 6 | 2018 | 411 | 0.800 |
Why?
| | Whole Genome Sequencing | 4 | 2025 | 183 | 0.800 |
Why?
| | Orthomyxoviridae | 1 | 2024 | 41 | 0.790 |
Why?
| | Polymorphism, Single Nucleotide | 14 | 2019 | 2240 | 0.790 |
Why?
| | Peptide Hydrolases | 3 | 2020 | 105 | 0.780 |
Why?
| | Influenza in Birds | 1 | 2023 | 5 | 0.770 |
Why?
| | Retroelements | 2 | 2018 | 50 | 0.770 |
Why?
| | Repressor Proteins | 7 | 2023 | 430 | 0.770 |
Why?
| | Hemorrhagic Fevers, Viral | 1 | 2022 | 16 | 0.740 |
Why?
| | Epidemiological Monitoring | 1 | 2023 | 70 | 0.730 |
Why?
| | Genetic Diseases, Inborn | 3 | 2023 | 45 | 0.730 |
Why?
| | Arterivirus | 1 | 2022 | 18 | 0.730 |
Why?
| | Neurofibromatosis 1 | 1 | 2023 | 59 | 0.720 |
Why?
| | Cell Cycle Proteins | 5 | 2016 | 630 | 0.720 |
Why?
| | Virus Diseases | 2 | 2016 | 219 | 0.720 |
Why?
| | Rhabdomyosarcoma | 1 | 2023 | 65 | 0.710 |
Why?
| | Dog Diseases | 2 | 2023 | 140 | 0.690 |
Why?
| | Phylogeny | 12 | 2019 | 924 | 0.690 |
Why?
| | Homozygote | 3 | 2021 | 197 | 0.680 |
Why?
| | Genetic Variation | 8 | 2018 | 996 | 0.680 |
Why?
| | RNA, Messenger | 5 | 2023 | 2791 | 0.660 |
Why?
| | Mammals | 5 | 2024 | 288 | 0.650 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2024 | 269 | 0.650 |
Why?
| | Cell Line | 11 | 2025 | 2814 | 0.640 |
Why?
| | Molecular Sequence Data | 18 | 2015 | 2838 | 0.640 |
Why?
| | Urogenital Abnormalities | 1 | 2021 | 71 | 0.640 |
Why?
| | Wnt Proteins | 1 | 2021 | 131 | 0.630 |
Why?
| | Congenital Abnormalities | 1 | 2021 | 108 | 0.630 |
Why?
| | Interferon Type I | 1 | 2021 | 147 | 0.620 |
Why?
| | Herpesvirus 1, Human | 3 | 2018 | 87 | 0.600 |
Why?
| | Species Specificity | 9 | 2018 | 543 | 0.590 |
Why?
| | Membrane Proteins | 3 | 2018 | 1130 | 0.580 |
Why?
| | Soft Tissue Neoplasms | 2 | 2018 | 133 | 0.580 |
Why?
| | Computational Biology | 7 | 2020 | 678 | 0.580 |
Why?
| | Virus Attachment | 2 | 2015 | 19 | 0.570 |
Why?
| | Genome, Viral | 3 | 2025 | 217 | 0.570 |
Why?
| | Polysaccharides | 1 | 2019 | 88 | 0.560 |
Why?
| | DNA-Binding Proteins | 8 | 2021 | 1468 | 0.560 |
Why?
| | Genes, BRCA2 | 4 | 2015 | 33 | 0.560 |
Why?
| | Arenaviruses, New World | 2 | 2015 | 9 | 0.550 |
Why?
| | Genes | 2 | 2015 | 215 | 0.550 |
Why?
| | HEK293 Cells | 7 | 2024 | 750 | 0.540 |
Why?
| | Transcription Factors | 4 | 2023 | 1730 | 0.530 |
Why?
| | Base Sequence | 12 | 2024 | 2123 | 0.530 |
Why?
| | Leukoencephalopathies | 1 | 2017 | 23 | 0.520 |
Why?
| | Hamartoma Syndrome, Multiple | 1 | 2017 | 16 | 0.520 |
Why?
| | Circulating Tumor DNA | 3 | 2022 | 50 | 0.510 |
Why?
| | BRCA1 Protein | 2 | 2014 | 84 | 0.510 |
Why?
| | DNA, Circular | 2 | 2014 | 15 | 0.510 |
Why?
| | Fibroma | 1 | 2017 | 21 | 0.500 |
Why?
| | Genome, Human | 9 | 2025 | 431 | 0.500 |
Why?
| | Genetic Predisposition to Disease | 12 | 2025 | 2488 | 0.500 |
Why?
| | Kidney Diseases | 1 | 2021 | 428 | 0.500 |
Why?
| | Lung Diseases, Interstitial | 1 | 2023 | 677 | 0.490 |
Why?
| | Ribonucleoproteins | 1 | 2017 | 106 | 0.480 |
Why?
| | Immediate-Early Proteins | 1 | 2016 | 46 | 0.480 |
Why?
| | DNA Repair Enzymes | 1 | 2016 | 29 | 0.480 |
Why?
| | Models, Biological | 1 | 2024 | 1761 | 0.480 |
Why?
| | PTEN Phosphohydrolase | 1 | 2017 | 166 | 0.480 |
Why?
| | Influenza A virus | 4 | 2023 | 120 | 0.470 |
Why?
| | Molecular Chaperones | 1 | 2018 | 200 | 0.470 |
Why?
| | Kidney | 2 | 2021 | 1498 | 0.460 |
Why?
| | Neurodevelopmental Disorders | 4 | 2024 | 239 | 0.460 |
Why?
| | Exoribonucleases | 1 | 2016 | 48 | 0.460 |
Why?
| | Macrophages | 1 | 2024 | 1532 | 0.460 |
Why?
| | Virus Physiological Phenomena | 2 | 2012 | 9 | 0.450 |
Why?
| | Lipomatosis, Multiple Symmetrical | 1 | 2015 | 1 | 0.450 |
Why?
| | Host-Parasite Interactions | 1 | 2016 | 109 | 0.450 |
Why?
| | Abnormalities, Multiple | 4 | 2024 | 195 | 0.440 |
Why?
| | Dogs | 5 | 2023 | 517 | 0.430 |
Why?
| | Fanconi Anemia | 1 | 2014 | 11 | 0.430 |
Why?
| | GTP Phosphohydrolases | 1 | 2015 | 95 | 0.430 |
Why?
| | Fungal Proteins | 3 | 2006 | 137 | 0.420 |
Why?
| | Histones | 2 | 2017 | 670 | 0.420 |
Why?
| | Recombination, Genetic | 3 | 2013 | 202 | 0.420 |
Why?
| | Multigene Family | 2 | 2013 | 210 | 0.420 |
Why?
| | Breast Neoplasms | 6 | 2015 | 2418 | 0.420 |
Why?
| | Child | 27 | 2026 | 22693 | 0.420 |
Why?
| | Embryonic Development | 1 | 2015 | 124 | 0.420 |
Why?
| | Retroviridae | 5 | 2011 | 99 | 0.420 |
Why?
| | Developmental Disabilities | 5 | 2025 | 281 | 0.410 |
Why?
| | DNA Repair | 3 | 2014 | 255 | 0.410 |
Why?
| | Polymorphism, Genetic | 6 | 2014 | 612 | 0.410 |
Why?
| | BRCA2 Protein | 1 | 2014 | 69 | 0.400 |
Why?
| | Cerebellar Ataxia | 1 | 2014 | 12 | 0.400 |
Why?
| | Peptidyl-Dipeptidase A | 2 | 2022 | 57 | 0.400 |
Why?
| | Ranavirus | 1 | 2013 | 6 | 0.390 |
Why?
| | Receptor Protein-Tyrosine Kinases | 1 | 2015 | 227 | 0.390 |
Why?
| | Proteins | 3 | 2016 | 1022 | 0.390 |
Why?
| | Cutis Laxa | 1 | 2013 | 2 | 0.390 |
Why?
| | Genes, Essential | 1 | 2013 | 19 | 0.390 |
Why?
| | Research Design | 5 | 2026 | 1143 | 0.390 |
Why?
| | Elastic Tissue | 1 | 2013 | 10 | 0.380 |
Why?
| | Mitochondrial Proteins | 1 | 2015 | 263 | 0.380 |
Why?
| | Exons | 4 | 2024 | 361 | 0.370 |
Why?
| | Ovarian Neoplasms | 5 | 2022 | 604 | 0.370 |
Why?
| | Genome, Fungal | 2 | 2018 | 48 | 0.370 |
Why?
| | Transcriptome | 1 | 2019 | 1068 | 0.360 |
Why?
| | Antigens, CD | 1 | 2015 | 560 | 0.360 |
Why?
| | Nervous System Diseases | 1 | 2015 | 288 | 0.350 |
Why?
| | Sequence Homology, Amino Acid | 5 | 2018 | 382 | 0.350 |
Why?
| | Plasmodium knowlesi | 1 | 2011 | 1 | 0.350 |
Why?
| | Extracellular Matrix Proteins | 1 | 2013 | 156 | 0.350 |
Why?
| | Plasmodium vivax | 1 | 2011 | 6 | 0.350 |
Why?
| | Duffy Blood-Group System | 1 | 2011 | 6 | 0.350 |
Why?
| | Transcription, Genetic | 2 | 2017 | 1432 | 0.340 |
Why?
| | Influenza, Human | 1 | 2017 | 640 | 0.340 |
Why?
| | Gene Frequency | 5 | 2011 | 496 | 0.340 |
Why?
| | Phenotype | 10 | 2023 | 3206 | 0.330 |
Why?
| | DNA, Viral | 1 | 2013 | 354 | 0.330 |
Why?
| | Flow Cytometry | 3 | 2024 | 1163 | 0.330 |
Why?
| | Ontario | 6 | 2026 | 91 | 0.310 |
Why?
| | Models, Molecular | 5 | 2017 | 1574 | 0.290 |
Why?
| | Receptors, Cell Surface | 2 | 2011 | 371 | 0.290 |
Why?
| | Protein Binding | 8 | 2019 | 2244 | 0.290 |
Why?
| | Child, Preschool | 17 | 2025 | 11913 | 0.290 |
Why?
| | Growth Disorders | 2 | 2020 | 89 | 0.290 |
Why?
| | Female | 36 | 2026 | 79499 | 0.280 |
Why?
| | Canada | 4 | 2025 | 432 | 0.280 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2011 | 429 | 0.280 |
Why?
| | Mutation, Missense | 4 | 2023 | 334 | 0.280 |
Why?
| | Microcephaly | 2 | 2020 | 106 | 0.280 |
Why?
| | Facies | 4 | 2023 | 22 | 0.270 |
Why?
| | Alleles | 5 | 2014 | 907 | 0.270 |
Why?
| | Sequence Alignment | 4 | 2019 | 360 | 0.270 |
Why?
| | A549 Cells | 2 | 2018 | 76 | 0.260 |
Why?
| | Epidemics | 2 | 2019 | 97 | 0.260 |
Why?
| | Gene Duplication | 2 | 2021 | 67 | 0.250 |
Why?
| | Polymerase Chain Reaction | 4 | 2016 | 1031 | 0.250 |
Why?
| | Molecular Diagnostic Techniques | 2 | 2021 | 104 | 0.250 |
Why?
| | DNA Transposable Elements | 2 | 2024 | 125 | 0.250 |
Why?
| | Saccharomyces | 1 | 2006 | 6 | 0.250 |
Why?
| | Germ-Line Mutation | 4 | 2023 | 180 | 0.250 |
Why?
| | Infant | 11 | 2025 | 10114 | 0.240 |
Why?
| | Viral Load | 2 | 2021 | 526 | 0.240 |
Why?
| | Haplotypes | 2 | 2005 | 506 | 0.240 |
Why?
| | Immunocompetence | 1 | 2026 | 46 | 0.230 |
Why?
| | Epilepsy | 2 | 2025 | 400 | 0.230 |
Why?
| | Protein Structure, Tertiary | 6 | 2012 | 834 | 0.230 |
Why?
| | Male | 25 | 2026 | 73396 | 0.220 |
Why?
| | Erythrocytes | 1 | 2011 | 750 | 0.220 |
Why?
| | Genotype | 6 | 2015 | 1879 | 0.220 |
Why?
| | Genetics, Medical | 1 | 2025 | 23 | 0.220 |
Why?
| | Culicidae | 1 | 2025 | 33 | 0.220 |
Why?
| | Replication Origin | 2 | 2004 | 17 | 0.220 |
Why?
| | Viremia | 1 | 2026 | 158 | 0.220 |
Why?
| | Genes, Viral | 4 | 2013 | 88 | 0.210 |
Why?
| | Nucleoside Deaminases | 1 | 2004 | 2 | 0.210 |
Why?
| | Receptor, Interferon alpha-beta | 1 | 2024 | 35 | 0.210 |
Why?
| | Aedes | 1 | 2025 | 67 | 0.210 |
Why?
| | Linkage Disequilibrium | 1 | 2005 | 260 | 0.210 |
Why?
| | Endogenous Retroviruses | 1 | 2005 | 37 | 0.210 |
Why?
| | Neoplasms | 2 | 2022 | 2954 | 0.210 |
Why?
| | DNA | 3 | 2004 | 1421 | 0.210 |
Why?
| | Musculoskeletal Abnormalities | 1 | 2024 | 13 | 0.210 |
Why?
| | Adult | 14 | 2026 | 41087 | 0.200 |
Why?
| | Nucleic Acid Hybridization | 2 | 2003 | 175 | 0.200 |
Why?
| | Carcinogenesis | 2 | 2016 | 226 | 0.200 |
Why?
| | Bone Diseases, Developmental | 1 | 2023 | 17 | 0.200 |
Why?
| | Tooth Abnormalities | 1 | 2023 | 17 | 0.200 |
Why?
| | Codon, Terminator | 1 | 2003 | 25 | 0.200 |
Why?
| | Megalencephaly | 1 | 2023 | 20 | 0.200 |
Why?
| | Signal Transduction | 5 | 2024 | 5246 | 0.200 |
Why?
| | Virion | 2 | 2021 | 112 | 0.190 |
Why?
| | Protein Interaction Domains and Motifs | 2 | 2016 | 145 | 0.190 |
Why?
| | Algorithms | 2 | 2025 | 1849 | 0.190 |
Why?
| | Cafe-au-Lait Spots | 1 | 2023 | 2 | 0.190 |
Why?
| | Vaginal Neoplasms | 1 | 2023 | 20 | 0.190 |
Why?
| | Chromatin Assembly and Disassembly | 1 | 2024 | 109 | 0.190 |
Why?
| | HIV | 1 | 2004 | 249 | 0.190 |
Why?
| | ATP-Binding Cassette Transporters | 1 | 2023 | 117 | 0.190 |
Why?
| | Triage | 1 | 2025 | 243 | 0.190 |
Why?
| | Macaca | 1 | 2022 | 66 | 0.180 |
Why?
| | Mutagenesis, Insertional | 2 | 2018 | 68 | 0.180 |
Why?
| | Birds | 1 | 2023 | 87 | 0.180 |
Why?
| | Alternative Splicing | 1 | 2024 | 253 | 0.180 |
Why?
| | Orthomyxoviridae Infections | 1 | 2023 | 72 | 0.180 |
Why?
| | Oligonucleotides | 1 | 2003 | 155 | 0.180 |
Why?
| | RNA Viruses | 2 | 2019 | 75 | 0.180 |
Why?
| | Mice | 10 | 2021 | 18297 | 0.180 |
Why?
| | Biomarkers | 2 | 2024 | 4340 | 0.180 |
Why?
| | Disease Models, Animal | 2 | 2026 | 4580 | 0.180 |
Why?
| | Universities | 2 | 2023 | 451 | 0.180 |
Why?
| | Alzheimer Disease | 3 | 2003 | 641 | 0.180 |
Why?
| | Decision Making | 2 | 2026 | 993 | 0.170 |
Why?
| | Wilms Tumor | 1 | 2023 | 91 | 0.170 |
Why?
| | DNA Methylation | 2 | 2024 | 725 | 0.170 |
Why?
| | Interferons | 2 | 2024 | 186 | 0.170 |
Why?
| | Nucleic Acid Amplification Techniques | 1 | 2021 | 39 | 0.170 |
Why?
| | Asymptomatic Infections | 1 | 2021 | 40 | 0.170 |
Why?
| | Pedigree | 4 | 2017 | 512 | 0.160 |
Why?
| | Monocytes | 1 | 2024 | 538 | 0.160 |
Why?
| | Urinary Tract | 1 | 2021 | 47 | 0.160 |
Why?
| | Viral Nonstructural Proteins | 2 | 2020 | 64 | 0.160 |
Why?
| | Gene Expression Profiling | 2 | 2024 | 1792 | 0.160 |
Why?
| | Ubiquitination | 2 | 2019 | 119 | 0.160 |
Why?
| | Macaca mulatta | 2 | 2019 | 188 | 0.160 |
Why?
| | Glycosylation | 2 | 2019 | 177 | 0.160 |
Why?
| | Chromosomes, Human, Pair 1 | 1 | 2021 | 82 | 0.160 |
Why?
| | Chromosome Disorders | 1 | 2021 | 46 | 0.160 |
Why?
| | Chromosomes, Human, X | 1 | 2021 | 76 | 0.160 |
Why?
| | Kidney Tubules | 1 | 2021 | 117 | 0.160 |
Why?
| | Acute Disease | 1 | 2023 | 1038 | 0.160 |
Why?
| | Blepharophimosis | 1 | 2020 | 4 | 0.160 |
Why?
| | Parents | 2 | 2026 | 1394 | 0.160 |
Why?
| | Genome-Wide Association Study | 3 | 2019 | 1537 | 0.160 |
Why?
| | Databases, Genetic | 3 | 2014 | 239 | 0.160 |
Why?
| | Fibroblasts | 2 | 2024 | 1034 | 0.160 |
Why?
| | Crowdsourcing | 1 | 2020 | 18 | 0.160 |
Why?
| | Eczema | 1 | 2020 | 66 | 0.150 |
Why?
| | Receptors, CCR5 | 2 | 2017 | 59 | 0.150 |
Why?
| | DNA Primers | 2 | 2015 | 487 | 0.150 |
Why?
| | RNA Virus Infections | 1 | 2019 | 20 | 0.150 |
Why?
| | Pandemics | 3 | 2023 | 1707 | 0.150 |
Why?
| | Flavivirus Infections | 1 | 2019 | 9 | 0.150 |
Why?
| | env Gene Products, Human Immunodeficiency Virus | 1 | 2019 | 15 | 0.150 |
Why?
| | Specimen Handling | 1 | 2021 | 178 | 0.150 |
Why?
| | RNA, Double-Stranded | 1 | 2019 | 58 | 0.150 |
Why?
| | Models, Genetic | 4 | 2006 | 540 | 0.150 |
Why?
| | Adolescent | 12 | 2026 | 22557 | 0.150 |
Why?
| | DNA Helicases | 1 | 2000 | 138 | 0.150 |
Why?
| | HIV Envelope Protein gp120 | 1 | 2019 | 55 | 0.140 |
Why?
| | Cytidine Deaminase | 2 | 2013 | 59 | 0.140 |
Why?
| | Histone Deacetylases | 1 | 2020 | 208 | 0.140 |
Why?
| | Viral Structural Proteins | 1 | 2018 | 12 | 0.140 |
Why?
| | Observational Studies as Topic | 3 | 2026 | 133 | 0.140 |
Why?
| | Myofibromatosis | 1 | 2018 | 10 | 0.140 |
Why?
| | HIV Seropositivity | 1 | 2019 | 118 | 0.140 |
Why?
| | Receptor, Platelet-Derived Growth Factor beta | 1 | 2018 | 32 | 0.140 |
Why?
| | Nucleotidyltransferases | 1 | 2018 | 30 | 0.140 |
Why?
| | Hemorrhagic Fever, Ebola | 1 | 2019 | 82 | 0.140 |
Why?
| | Alopecia | 1 | 2018 | 33 | 0.140 |
Why?
| | Kidney Neoplasms | 1 | 2023 | 419 | 0.140 |
Why?
| | Longitudinal Studies | 1 | 2026 | 3017 | 0.140 |
Why?
| | Sequence Homology | 1 | 2018 | 43 | 0.140 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2019 | 155 | 0.140 |
Why?
| | DNA, Fungal | 1 | 2018 | 76 | 0.130 |
Why?
| | DEAD Box Protein 58 | 1 | 2017 | 7 | 0.130 |
Why?
| | SUMO-1 Protein | 1 | 2017 | 19 | 0.130 |
Why?
| | Africa | 1 | 2018 | 119 | 0.130 |
Why?
| | Acetyltransferases | 1 | 2017 | 27 | 0.130 |
Why?
| | Cost-Benefit Analysis | 3 | 2025 | 640 | 0.130 |
Why?
| | Infant Nutritional Physiological Phenomena | 1 | 2019 | 159 | 0.130 |
Why?
| | Charcot-Marie-Tooth Disease | 1 | 2017 | 22 | 0.130 |
Why?
| | Pathology, Molecular | 1 | 2017 | 28 | 0.130 |
Why?
| | Intelligence | 1 | 2017 | 119 | 0.130 |
Why?
| | Callithrix | 1 | 2016 | 10 | 0.130 |
Why?
| | Membrane Transport Proteins | 1 | 2018 | 154 | 0.130 |
Why?
| | Hylobates | 1 | 2016 | 8 | 0.130 |
Why?
| | Pongo | 1 | 2016 | 7 | 0.120 |
Why?
| | Electronic Health Records | 1 | 2025 | 1210 | 0.120 |
Why?
| | Totivirus | 1 | 2016 | 1 | 0.120 |
Why?
| | Infant, Newborn | 4 | 2018 | 6460 | 0.120 |
Why?
| | RNA-Binding Proteins | 1 | 2021 | 465 | 0.120 |
Why?
| | Chondroblastoma | 1 | 2016 | 3 | 0.120 |
Why?
| | Brachydactyly | 1 | 2016 | 2 | 0.120 |
Why?
| | Behavior Therapy | 1 | 2019 | 291 | 0.120 |
Why?
| | Dysarthria | 1 | 2016 | 10 | 0.120 |
Why?
| | Spinocerebellar Ataxias | 1 | 2016 | 6 | 0.120 |
Why?
| | Prospective Studies | 6 | 2026 | 8123 | 0.120 |
Why?
| | Receptors, Immunologic | 1 | 2017 | 210 | 0.120 |
Why?
| | Immunoprecipitation | 1 | 2016 | 150 | 0.120 |
Why?
| | Immunoblotting | 1 | 2016 | 294 | 0.120 |
Why?
| | Genetic Association Studies | 2 | 2015 | 379 | 0.120 |
Why?
| | Young Adult | 7 | 2021 | 14330 | 0.120 |
Why?
| | Spastic Paraplegia, Hereditary | 1 | 2016 | 13 | 0.120 |
Why?
| | Autism Spectrum Disorder | 2 | 2021 | 406 | 0.120 |
Why?
| | Capsid | 3 | 2012 | 94 | 0.120 |
Why?
| | Sensitivity and Specificity | 1 | 2021 | 1998 | 0.120 |
Why?
| | Cell Differentiation | 1 | 2024 | 1982 | 0.120 |
Why?
| | Peptide Chain Elongation, Translational | 1 | 2015 | 18 | 0.120 |
Why?
| | Protein Interaction Mapping | 1 | 2016 | 105 | 0.120 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2016 | 371 | 0.120 |
Why?
| | Immunity, Innate | 3 | 2024 | 844 | 0.110 |
Why?
| | Filoviridae | 1 | 2015 | 27 | 0.110 |
Why?
| | Disease Resistance | 1 | 2015 | 30 | 0.110 |
Why?
| | Muscle Spasticity | 1 | 2016 | 63 | 0.110 |
Why?
| | Antiviral Agents | 2 | 2021 | 779 | 0.110 |
Why?
| | White Matter | 1 | 2017 | 169 | 0.110 |
Why?
| | Activin Receptors, Type I | 1 | 2015 | 6 | 0.110 |
Why?
| | Heat-Shock Proteins | 1 | 2016 | 140 | 0.110 |
Why?
| | Myositis Ossificans | 1 | 2015 | 4 | 0.110 |
Why?
| | Hallux Valgus | 1 | 2015 | 10 | 0.110 |
Why?
| | Neanderthals | 1 | 2015 | 13 | 0.110 |
Why?
| | Molecular Docking Simulation | 1 | 2015 | 121 | 0.110 |
Why?
| | Blotting, Western | 2 | 2016 | 1177 | 0.110 |
Why?
| | Tuberculosis | 1 | 2018 | 290 | 0.110 |
Why?
| | Fanconi Anemia Complementation Group Proteins | 1 | 2014 | 7 | 0.110 |
Why?
| | Gene Expression | 2 | 2011 | 1463 | 0.110 |
Why?
| | Extinction, Biological | 1 | 2015 | 34 | 0.110 |
Why?
| | Vesicle-Associated Membrane Protein 1 | 1 | 2014 | 2 | 0.110 |
Why?
| | Acclimatization | 1 | 2016 | 169 | 0.110 |
Why?
| | Craniofacial Abnormalities | 1 | 2015 | 78 | 0.110 |
Why?
| | HIV-2 | 1 | 2014 | 18 | 0.100 |
Why?
| | Transfection | 1 | 2016 | 916 | 0.100 |
Why?
| | Colorado | 2 | 2023 | 4595 | 0.100 |
Why?
| | Morphogenesis | 1 | 2015 | 163 | 0.100 |
Why?
| | Siblings | 1 | 2015 | 202 | 0.100 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2016 | 213 | 0.100 |
Why?
| | Monomeric GTP-Binding Proteins | 1 | 2014 | 16 | 0.100 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2017 | 457 | 0.100 |
Why?
| | Syndrome | 1 | 2015 | 380 | 0.100 |
Why?
| | Gene Rearrangement | 1 | 2015 | 156 | 0.100 |
Why?
| | Ribosomes | 1 | 2015 | 196 | 0.100 |
Why?
| | Hemiplegia | 1 | 2014 | 20 | 0.100 |
Why?
| | Respiratory Distress Syndrome, Newborn | 1 | 2015 | 104 | 0.100 |
Why?
| | Chromosome Mapping | 3 | 2005 | 508 | 0.100 |
Why?
| | Consanguinity | 1 | 2014 | 50 | 0.100 |
Why?
| | Dystonic Disorders | 1 | 2014 | 27 | 0.100 |
Why?
| | Sodium-Potassium-Exchanging ATPase | 1 | 2014 | 55 | 0.100 |
Why?
| | Peer Review, Research | 1 | 2014 | 36 | 0.100 |
Why?
| | Botulinum Toxins | 1 | 2014 | 49 | 0.100 |
Why?
| | Magnetic Resonance Imaging | 2 | 2017 | 3926 | 0.100 |
Why?
| | Sarcoma | 1 | 2016 | 209 | 0.100 |
Why?
| | Bone Neoplasms | 1 | 2016 | 272 | 0.100 |
Why?
| | Gene Library | 1 | 2013 | 121 | 0.100 |
Why?
| | Chromosomal Proteins, Non-Histone | 3 | 2004 | 131 | 0.100 |
Why?
| | Colorectal Neoplasms | 1 | 2021 | 874 | 0.100 |
Why?
| | Adaptation, Biological | 1 | 2013 | 48 | 0.100 |
Why?
| | Membrane Glycoproteins | 1 | 2015 | 495 | 0.090 |
Why?
| | Nervous System Malformations | 1 | 2013 | 47 | 0.090 |
Why?
| | Amphibians | 1 | 2013 | 55 | 0.090 |
Why?
| | Mass Screening | 1 | 2021 | 1307 | 0.090 |
Why?
| | Middle Aged | 6 | 2025 | 36619 | 0.090 |
Why?
| | Parvovirus, Canine | 1 | 2012 | 1 | 0.090 |
Why?
| | Canidae | 1 | 2012 | 1 | 0.090 |
Why?
| | Parvoviridae Infections | 1 | 2012 | 12 | 0.090 |
Why?
| | Brain | 3 | 2015 | 2991 | 0.090 |
Why?
| | DNA Mutational Analysis | 4 | 2014 | 410 | 0.090 |
Why?
| | Neoplastic Stem Cells | 1 | 2016 | 403 | 0.090 |
Why?
| | mRNA Cleavage and Polyadenylation Factors | 1 | 2012 | 28 | 0.090 |
Why?
| | Cluster Analysis | 1 | 2013 | 496 | 0.090 |
Why?
| | Family Health | 1 | 2012 | 194 | 0.090 |
Why?
| | Endoribonucleases | 2 | 2022 | 80 | 0.080 |
Why?
| | Chordata | 1 | 2011 | 5 | 0.080 |
Why?
| | Neoplasm Recurrence, Local | 3 | 2023 | 1160 | 0.080 |
Why?
| | Gene Dosage | 1 | 2011 | 146 | 0.080 |
Why?
| | Retroviridae Infections | 2 | 2009 | 47 | 0.080 |
Why?
| | DNA Polymerase beta | 1 | 2010 | 6 | 0.080 |
Why?
| | Endonucleases | 1 | 2010 | 35 | 0.080 |
Why?
| | Biomarkers, Tumor | 3 | 2022 | 1339 | 0.080 |
Why?
| | Hospitalization | 1 | 2021 | 2475 | 0.080 |
Why?
| | Iron | 1 | 2013 | 359 | 0.080 |
Why?
| | Protein Structure, Secondary | 1 | 2011 | 357 | 0.080 |
Why?
| | Multicenter Studies as Topic | 2 | 2022 | 417 | 0.080 |
Why?
| | Endodeoxyribonucleases | 1 | 2010 | 77 | 0.080 |
Why?
| | DNA Breaks, Double-Stranded | 1 | 2010 | 55 | 0.080 |
Why?
| | Lung | 1 | 2023 | 4122 | 0.080 |
Why?
| | Gene Conversion | 1 | 1989 | 7 | 0.080 |
Why?
| | Vero Cells | 2 | 2019 | 84 | 0.070 |
Why?
| | Genetic Techniques | 1 | 1989 | 64 | 0.070 |
Why?
| | Fetal Growth Retardation | 1 | 2015 | 592 | 0.070 |
Why?
| | Rodentia | 1 | 2009 | 63 | 0.070 |
Why?
| | Statistics as Topic | 1 | 1989 | 279 | 0.070 |
Why?
| | Estrogens | 1 | 2011 | 364 | 0.070 |
Why?
| | Pregnancy | 1 | 2021 | 7230 | 0.070 |
Why?
| | Survival Rate | 1 | 2013 | 2092 | 0.070 |
Why?
| | Chromosome Deletion | 2 | 2021 | 127 | 0.070 |
Why?
| | Reverse Transcription | 1 | 2007 | 20 | 0.070 |
Why?
| | Retrospective Studies | 4 | 2025 | 17438 | 0.070 |
Why?
| | Minor Histocompatibility Antigens | 1 | 2007 | 47 | 0.060 |
Why?
| | Cell Line, Tumor | 1 | 2015 | 3545 | 0.060 |
Why?
| | Binding Sites | 1 | 2010 | 1309 | 0.060 |
Why?
| | Randomized Controlled Trials as Topic | 2 | 2025 | 1763 | 0.060 |
Why?
| | Minichromosome Maintenance Proteins | 2 | 2004 | 6 | 0.060 |
Why?
| | Genetics, Population | 2 | 2006 | 226 | 0.060 |
Why?
| | Adaptation, Physiological | 1 | 2010 | 568 | 0.060 |
Why?
| | Meiosis | 1 | 2006 | 102 | 0.060 |
Why?
| | Genomic Instability | 1 | 2006 | 64 | 0.060 |
Why?
| | Students | 2 | 2023 | 649 | 0.060 |
Why?
| | Factor Analysis, Statistical | 1 | 2026 | 298 | 0.060 |
Why?
| | Cattle | 1 | 2007 | 940 | 0.050 |
Why?
| | Point Mutation | 2 | 2018 | 232 | 0.050 |
Why?
| | Chromosomes, Human, Pair 10 | 1 | 2004 | 21 | 0.050 |
Why?
| | vif Gene Products, Human Immunodeficiency Virus | 1 | 2004 | 3 | 0.050 |
Why?
| | APOBEC-1 Deaminase | 1 | 2004 | 5 | 0.050 |
Why?
| | APOBEC-3G Deaminase | 1 | 2004 | 5 | 0.050 |
Why?
| | Gene Products, vif | 1 | 2004 | 2 | 0.050 |
Why?
| | APOBEC Deaminases | 1 | 2004 | 6 | 0.050 |
Why?
| | Cats | 2 | 2019 | 226 | 0.050 |
Why?
| | RNA Editing | 1 | 2004 | 26 | 0.050 |
Why?
| | Limb Deformities, Congenital | 1 | 2024 | 22 | 0.050 |
Why?
| | T-Lymphocytes | 1 | 2013 | 2012 | 0.050 |
Why?
| | Phosphotransferases | 1 | 2024 | 26 | 0.050 |
Why?
| | Genomic Structural Variation | 1 | 2024 | 13 | 0.050 |
Why?
| | Muscle Hypotonia | 1 | 2024 | 34 | 0.050 |
Why?
| | Likelihood Functions | 1 | 2004 | 138 | 0.050 |
Why?
| | Minichromosome Maintenance Complex Component 7 | 2 | 2000 | 3 | 0.050 |
Why?
| | rab5 GTP-Binding Proteins | 1 | 2023 | 10 | 0.050 |
Why?
| | Catalysis | 1 | 2004 | 304 | 0.050 |
Why?
| | False Positive Reactions | 1 | 2003 | 124 | 0.050 |
Why?
| | Surveys and Questionnaires | 2 | 2026 | 6073 | 0.050 |
Why?
| | Protein Isoforms | 1 | 2024 | 391 | 0.050 |
Why?
| | Plant Viruses | 1 | 2003 | 12 | 0.050 |
Why?
| | rab GTP-Binding Proteins | 1 | 2023 | 76 | 0.050 |
Why?
| | Sequence Deletion | 1 | 2003 | 190 | 0.050 |
Why?
| | Acquired Immunodeficiency Syndrome | 1 | 2004 | 238 | 0.050 |
Why?
| | Muscle Proteins | 1 | 2004 | 242 | 0.050 |
Why?
| | Monkeypox virus | 1 | 2022 | 23 | 0.050 |
Why?
| | Genetic Markers | 1 | 2003 | 340 | 0.050 |
Why?
| | Neuroblastoma | 1 | 2024 | 177 | 0.050 |
Why?
| | Risk Factors | 3 | 2012 | 10921 | 0.050 |
Why?
| | Psychometrics | 1 | 2026 | 712 | 0.050 |
Why?
| | Masks | 1 | 2023 | 70 | 0.040 |
Why?
| | Focus Groups | 1 | 2025 | 588 | 0.040 |
Why?
| | Cytoplasm | 1 | 2022 | 253 | 0.040 |
Why?
| | Patient Reported Outcome Measures | 1 | 2026 | 516 | 0.040 |
Why?
| | Arachis | 1 | 2003 | 108 | 0.040 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2003 | 752 | 0.040 |
Why?
| | Spike Glycoprotein, Coronavirus | 1 | 2022 | 129 | 0.040 |
Why?
| | Neuroimaging | 1 | 2023 | 307 | 0.040 |
Why?
| | Minichromosome Maintenance Complex Component 4 | 1 | 2000 | 1 | 0.040 |
Why?
| | Minichromosome Maintenance Complex Component 3 | 1 | 2000 | 2 | 0.040 |
Why?
| | Reactive Oxygen Species | 1 | 2024 | 610 | 0.040 |
Why?
| | Attitude | 1 | 2023 | 253 | 0.040 |
Why?
| | Haploinsufficiency | 1 | 2021 | 53 | 0.040 |
Why?
| | Oligopeptides | 1 | 2022 | 264 | 0.040 |
Why?
| | Computer Simulation | 1 | 2025 | 1014 | 0.040 |
Why?
| | Dimerization | 1 | 2000 | 174 | 0.040 |
Why?
| | Knowledge Bases | 1 | 2020 | 28 | 0.040 |
Why?
| | B-Lymphocytes | 1 | 2006 | 887 | 0.040 |
Why?
| | Geminiviridae | 1 | 1999 | 1 | 0.040 |
Why?
| | Caenorhabditis elegans | 1 | 2023 | 330 | 0.040 |
Why?
| | Immunologic Factors | 1 | 2022 | 244 | 0.040 |
Why?
| | Catalytic Domain | 1 | 2000 | 235 | 0.040 |
Why?
| | DNA Copy Number Variations | 1 | 2020 | 192 | 0.040 |
Why?
| | Histone Acetyltransferases | 1 | 2020 | 57 | 0.040 |
Why?
| | Flavivirus | 1 | 2019 | 19 | 0.040 |
Why?
| | Cloning, Molecular | 2 | 2011 | 526 | 0.040 |
Why?
| | Disease Outbreaks | 1 | 2022 | 422 | 0.040 |
Why?
| | HeLa Cells | 1 | 2000 | 636 | 0.040 |
Why?
| | Zebrafish | 1 | 2023 | 536 | 0.040 |
Why?
| | Philippines | 1 | 2018 | 50 | 0.040 |
Why?
| | Referral and Consultation | 1 | 2025 | 881 | 0.040 |
Why?
| | Skull | 1 | 2020 | 162 | 0.030 |
Why?
| | Nucleotides, Cyclic | 1 | 2018 | 22 | 0.030 |
Why?
| | Proteolysis | 1 | 2019 | 174 | 0.030 |
Why?
| | Substrate Specificity | 1 | 2019 | 389 | 0.030 |
Why?
| | Genes, Recessive | 1 | 2018 | 77 | 0.030 |
Why?
| | Reproducibility of Results | 1 | 2026 | 3416 | 0.030 |
Why?
| | DNA Replication | 1 | 2000 | 248 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2003 | 2113 | 0.030 |
Why?
| | Age Distribution | 1 | 2018 | 399 | 0.030 |
Why?
| | Capsid Proteins | 2 | 2012 | 94 | 0.030 |
Why?
| | Encephalitis, Viral | 1 | 1997 | 45 | 0.030 |
Why?
| | Developing Countries | 1 | 2019 | 312 | 0.030 |
Why?
| | Immunotherapy | 1 | 2022 | 671 | 0.030 |
Why?
| | Herpes Simplex | 1 | 1997 | 103 | 0.030 |
Why?
| | Langer-Giedion Syndrome | 1 | 2016 | 2 | 0.030 |
Why?
| | Hair Diseases | 1 | 2016 | 9 | 0.030 |
Why?
| | Pilot Projects | 1 | 2022 | 1888 | 0.030 |
Why?
| | Cycloheximide | 1 | 2015 | 42 | 0.030 |
Why?
| | Epigenesis, Genetic | 1 | 2021 | 712 | 0.030 |
Why?
| | Nose | 1 | 2016 | 67 | 0.030 |
Why?
| | Polycomb Repressive Complex 1 | 1 | 2016 | 65 | 0.030 |
Why?
| | Dendritic Cells | 1 | 2019 | 509 | 0.030 |
Why?
| | Protein Synthesis Inhibitors | 1 | 2015 | 48 | 0.030 |
Why?
| | Methyltransferases | 1 | 2016 | 74 | 0.030 |
Why?
| | Methylation | 1 | 2016 | 241 | 0.030 |
Why?
| | Fingers | 1 | 2016 | 106 | 0.030 |
Why?
| | Codon | 1 | 2015 | 92 | 0.030 |
Why?
| | Guanylate Kinases | 1 | 2015 | 13 | 0.030 |
Why?
| | Chromosomes, Human, Pair 2 | 1 | 2015 | 28 | 0.030 |
Why?
| | Tooth, Deciduous | 1 | 2015 | 19 | 0.030 |
Why?
| | Methionine | 1 | 2016 | 160 | 0.030 |
Why?
| | Incisor | 1 | 2015 | 22 | 0.030 |
Why?
| | Population Surveillance | 1 | 2018 | 481 | 0.030 |
Why?
| | Genome, Mitochondrial | 1 | 2015 | 26 | 0.030 |
Why?
| | Dental Enamel | 1 | 2015 | 67 | 0.030 |
Why?
| | Archaeology | 1 | 2015 | 36 | 0.030 |
Why?
| | Multiplex Polymerase Chain Reaction | 1 | 2015 | 56 | 0.030 |
Why?
| | RNA, Transfer | 1 | 2015 | 142 | 0.030 |
Why?
| | Thyroid Gland | 1 | 2015 | 93 | 0.030 |
Why?
| | Paresis | 1 | 2014 | 30 | 0.030 |
Why?
| | Deoxyribonucleotides | 1 | 2014 | 20 | 0.030 |
Why?
| | Myopathies, Structural, Congenital | 1 | 2014 | 4 | 0.030 |
Why?
| | Fatal Outcome | 1 | 2015 | 302 | 0.030 |
Why?
| | SAM Domain and HD Domain-Containing Protein 1 | 1 | 2014 | 12 | 0.030 |
Why?
| | Diaphragm | 1 | 2014 | 45 | 0.030 |
Why?
| | Interferon-gamma | 1 | 1997 | 781 | 0.030 |
Why?
| | Nucleosomes | 1 | 2016 | 168 | 0.030 |
Why?
| | Mice, Knockout | 2 | 2018 | 3125 | 0.030 |
Why?
| | Machine Learning | 1 | 2020 | 594 | 0.030 |
Why?
| | Long Interspersed Nucleotide Elements | 1 | 2014 | 36 | 0.030 |
Why?
| | Financing, Organized | 1 | 2014 | 36 | 0.030 |
Why?
| | DNA, Mitochondrial | 1 | 2015 | 212 | 0.020 |
Why?
| | Uterus | 1 | 2015 | 227 | 0.020 |
Why?
| | Lysine | 1 | 2016 | 303 | 0.020 |
Why?
| | Prognosis | 1 | 2022 | 4351 | 0.020 |
Why?
| | Cytokines | 1 | 2021 | 2081 | 0.020 |
Why?
| | Time Factors | 1 | 2004 | 7109 | 0.020 |
Why?
| | RING Finger Domains | 1 | 2013 | 4 | 0.020 |
Why?
| | Rats | 2 | 2014 | 5586 | 0.020 |
Why?
| | Meta-Analysis as Topic | 1 | 2014 | 173 | 0.020 |
Why?
| | Brain Diseases | 1 | 2014 | 159 | 0.020 |
Why?
| | Loss of Heterozygosity | 1 | 2013 | 51 | 0.020 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2023 | 1998 | 0.020 |
Why?
| | Risk | 1 | 2015 | 920 | 0.020 |
Why?
| | Transferrin | 1 | 2012 | 48 | 0.020 |
Why?
| | Cell Transformation, Viral | 1 | 1992 | 23 | 0.020 |
Why?
| | Amino Acid Substitution | 1 | 2013 | 297 | 0.020 |
Why?
| | CHO Cells | 1 | 2012 | 167 | 0.020 |
Why?
| | Motor Neurons | 1 | 2014 | 239 | 0.020 |
Why?
| | Penetrance | 1 | 2011 | 30 | 0.020 |
Why?
| | Cricetinae | 1 | 2012 | 296 | 0.020 |
Why?
| | Erythropoiesis | 1 | 1992 | 57 | 0.020 |
Why?
| | Amino Acid Motifs | 1 | 2012 | 218 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2023 | 5899 | 0.020 |
Why?
| | Aromatase | 1 | 2011 | 37 | 0.020 |
Why?
| | Erythropoietin | 1 | 1992 | 100 | 0.020 |
Why?
| | DNA, Complementary | 1 | 2011 | 269 | 0.020 |
Why?
| | Mice, Inbred C57BL | 2 | 2018 | 6034 | 0.020 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2016 | 1432 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2017 | 4118 | 0.020 |
Why?
| | Crystallography, X-Ray | 1 | 2011 | 477 | 0.020 |
Why?
| | Genes, Bacterial | 1 | 1989 | 151 | 0.020 |
Why?
| | Apoptosis | 1 | 1997 | 2439 | 0.020 |
Why?
| | Models, Statistical | 2 | 2004 | 669 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 1 | 2014 | 2537 | 0.020 |
Why?
| | Neurons | 1 | 1997 | 1668 | 0.020 |
Why?
| | Receptors, Estrogen | 1 | 2011 | 406 | 0.020 |
Why?
| | Hematopoietic Stem Cells | 1 | 1992 | 432 | 0.020 |
Why?
| | Family | 1 | 2013 | 690 | 0.020 |
Why?
| | Comorbidity | 1 | 2011 | 1665 | 0.020 |
Why?
| | Expressed Sequence Tags | 1 | 2006 | 43 | 0.010 |
Why?
| | Heart Defects, Congenital | 1 | 2014 | 923 | 0.010 |
Why?
| | Escherichia coli | 1 | 1989 | 832 | 0.010 |
Why?
| | Aged | 2 | 2015 | 26432 | 0.010 |
Why?
| | Africa, Western | 1 | 2003 | 21 | 0.010 |
Why?
| | Cohort Studies | 1 | 2014 | 6077 | 0.010 |
Why?
| | Bacterial Proteins | 1 | 1989 | 980 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2015 | 8391 | 0.010 |
Why?
| | India | 1 | 2003 | 213 | 0.010 |
Why?
| | Conserved Sequence | 1 | 2003 | 242 | 0.010 |
Why?
| | Open Reading Frames | 1 | 2003 | 130 | 0.010 |
Why?
| | Sample Size | 1 | 2001 | 124 | 0.010 |
Why?
| | Sweden | 1 | 2001 | 114 | 0.010 |
Why?
| | Genetic Linkage | 1 | 2001 | 271 | 0.010 |
Why?
| | Two-Hybrid System Techniques | 1 | 2000 | 59 | 0.010 |
Why?
| | Crosses, Genetic | 1 | 2000 | 120 | 0.010 |
Why?
| | G1 Phase | 1 | 2000 | 64 | 0.010 |
Why?
| | Gene Deletion | 1 | 2001 | 385 | 0.010 |
Why?
| | Plasmids | 1 | 2000 | 373 | 0.010 |
Why?
| | Temperature | 1 | 2000 | 635 | 0.010 |
Why?
| | Cell Cycle | 1 | 2000 | 595 | 0.010 |
Why?
| | Interleukin-4 | 1 | 1997 | 207 | 0.010 |
Why?
| | Antigens, Viral | 1 | 1997 | 186 | 0.010 |
Why?
| | Eye | 1 | 1997 | 112 | 0.010 |
Why?
| | Chromatin | 1 | 2000 | 559 | 0.010 |
Why?
| | Defective Viruses | 1 | 1992 | 5 | 0.010 |
Why?
| | Interleukin-3 | 1 | 1992 | 23 | 0.010 |
Why?
| | Receptors, Erythropoietin | 1 | 1992 | 21 | 0.010 |
Why?
| | Gene Expression Regulation, Viral | 1 | 1992 | 92 | 0.010 |
Why?
| | Fluorouracil | 1 | 1992 | 231 | 0.010 |
Why?
| | Recombinant Fusion Proteins | 1 | 1992 | 663 | 0.000 |
Why?
| | Inflammation | 1 | 1997 | 2919 | 0.000 |
Why?
|
|
Sawyer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|